Same Indication

Pembrolizumab vs Trimethoprim

Pembrolizumab vs Trimethoprim: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Trimethoprim.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days; Trimethoprim β€” 8-10 hours.

Chemical Properties

Molecular Formula: Trimethoprim β€” C14H18N4O3.

Molecular Weight: Trimethoprim β€” 290.3180 g/mol.

Type: Pembrolizumab β€” Antibody; Trimethoprim β€” Small molecule.